Special Issue "Orally Disintegrating Films—Pharmaceutical Development for Improved Bioperformance"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: closed (31 March 2021) | Viewed by 13618
Special Issue Editor

Interests: patient-centric drug product design; oral drug delivery; advanced solid dosage forms; additive manufacturing; bioperformance prediction
Special Issue Information
Dear Colleagues,
Orally disintegrating films (ODFs) have emerged as innovative oral dosage forms which may combine flexible dosing and a high level of medication adherence, thus meeting the criteria for patient-centric drug product design. Although their potential advantages in pharmacotherapy are well recognized, there is still a lot of research work to be done in order to explore and understand the complex relationship among different formulation factors, film mechanical properties, and their bioperformance.
This Special Issue aims to compile the most recent findings related to ODF development and characterization and extend the knowledge base, which would facilitate future product development. Contributions related to different aspects of ODF development, including different approaches to increase drug load and incorporate poorly soluble drugs; applicability of different manufacturing methods and their potential scale-up to industrial level; development of relevant in vitro, in vivo, and in silico methods for ODF characterization and bioperformance prediction are welcomed.
Prof. Dr. Jelena Parojčić
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- orally disintegrating films
- pharmaceutical development
- film forming polymers
- additive manufacturing
- in vitro, in vivo, and in silico characterization
- scale-up
- bioperformance